White label – Pompe disease - ClinicalTrials.eu

Study on Salbutamol for Improving Muscle Strength in Patients with Congenital Myopathy

Not recruiting

3 1 1 1
Investigated Diseases:
- Congenital myopathy
Investigated Drugs:
- Salbutamol
Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Not recruiting

2 1 1

+5
Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Not recruiting

3 1 1 1
Investigated Diseases:
- Medication overuse headache
- Migraine
Investigated Drugs:
- Eptinezumab
+2
Study on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care

Not recruiting

3 1 1
Investigated Diseases:
- Eosinophilic granulomatosis with polyangiitis
Investigated Drugs:
Study of Retifanlimab, Capecitabine, and Oxaliplatin for First-Line Treatment in Patients with Metastatic Esophagogastric Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
- Gastrooesophageal cancer
Investigated Drugs:
- Retifanlimab
Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Metastatic Prostate Cancer

Not recruiting

3 1 1
Investigated Drugs:
+4
Study of Rilvegostomig (AZD2936) for Adults with Advanced or Metastatic Non-Small Cell Lung Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Lung neoplasm malignant
Investigated Drugs:
- Rilvegostomig
Study on Teclistamab and Drug Combination for Newly Diagnosed Multiple Myeloma Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Study on the Safety of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients with Acute Ischemic Stroke

Not recruiting

2 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Allogeneic Adipose-Derived Mesenchymal Stem Cells Expanded
Study on Durvalumab with Trimodality Therapy for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma stage II
- Bladder transitional cell carcinoma stage III
Investigated Drugs:
- Durvalumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies